The Beginning of a New Era in RSV Control

• 2023

  Log in to bookmark this resource.

  Log in
• Cody Meissner
PMID: 37682622DOI: https://dx.doi.org/10.1542/peds.2023-063817

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This commentary discusses the historical development and recent advancements in RSV control, focusing on antiviral therapy, passive immunoprophylaxis, and vaccines. It highlights the licensing of nirsevimab as a breakthrough in RSV prophylaxis for infants and young children, along with the development of stabilized recombinant preF RSV subunit vaccines for adults and pregnant individuals. The text emphasizes the importance of molecular biology research in understanding RSV and hints at future possibilities for RSV control, including potential challenges such as viral mutations. Overall, the article provides valuable insights into the ongoing efforts to combat RSV infections.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Antibodies, Monoclonal; Antiviral Agents; Immunization, Passive; Infant, Newborn; Maternal-Fetal Exchange; Pediatrics; Pregnancy Complications, Infectious; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Vaccines; Vaccines, Synthetic; Palivizumab; Antibodies, Monoclonal, Humanized

Institutions: Dartmouth-Hitchcock Medical Center

---

More like this

Pre-Pandemic Planning Survey of Healthcare Workers at a Tertiary Care Children's Hospital: Ethical and Workforce Issues 2010 · University of Colorado, Keesler Medical Center Ethical Obligations Regarding Short-Term Global Health Clinical Experiences: An American College of Physicians Position Paper 2018 · Johns Hopkins University, National Center for Ethics in Health Care, U.S. Department of Veterans Affairs, University of California –San Diego School of Medicine, University of California, San Diego, Virginia Mason Medical Center Outpatient Respiratory Syncytial Virus Infections and Novel Preventive Interventions 2024 · University Medical Center Utrecht, Respiratory Syncytial Virus NETwork (ReSViNET) Foundation

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---